With at least 5 trials going on in 2015 alone and Leo just waiting for the opportune time to submit I don't think it will take long. Waiting is wise at this point imo, and as Leo mentioned. There are plenty of catalysts along the way to get us there. Cellceutix/Leo has the maturity that will ensure that when the time is right and everything is in place it will go smoothly. There are certainly companies that don't follow through very well with the foresight and fortitude to get it right. Take a look at cvsl as an example. We're looking pretty good imo.
Market Data 
Markets 
AI
